Abstract
Activation of trypsinogen in acute pancreatitis results in subsequent increases in plasma levels of trypsin bound to the inhibitors α1-protease inhibitor (α1-PI) and α-macroglobulin (α-M). It seems logical to speculate that plasma levels of these inhibitor-bound forms of trypsin may reflect the degree of intrapancreatic zymogen activation and that determination of such parameters may be of diagnostic and prognostic value. In order to test this hypothesis, the concentrations of trypsinogen and of trypsin bound to α1-PI have been determined in serial plasma samples from rats who died (N=7) and survived (N=5) following induction of pancreatitis with taurocholate. Since the other major reaction product of active trypsin in plasma, α-macroglobulin-bound trypsin, cannot be measured directly, the plasma levels of trypsin-like amidase activity were determined to estimate the concentration of trypsin-α-M complex. Shortly after induction of pancreatitis, elevated levels of trypsinogen were present in plasma, but no α1-PI-bound trypsin could be detected. Trypsin-α1-PI complex continuously increased over the time course of pancreatitis in animals that died. In contrast, the plasma levels of trypsin-α1-PI complex were lower in animals that survived, peaked around 15 hr postinduction at levels (182±53 ng/ml) significantly lower than those in dying animals (543±346 ng/ml), and fell during the following 48 hr. There was a significant correlation between plasma trypsin-like amidase activity and plasma α1-PI-bound trypsin. Our data demonstrate that the concentration of activated forms of plasma trypsin in the bloodstream are correlated with mortality in experimental pancreatitis.
Similar content being viewed by others
References
Trapnell JE: Pathophysiology of acute pancreatitis. World J Surg 5:319–327, 1981
Creutzfeldt W, Schmidt H: Aetiology and pathogenesis of pancreatitis. Scand J Gastroenterol Suppl. 6:47–62, 1970
Lankisch PG, Rahlf G, Koop H: Pulmonary complications in fatal acute hemorrhagic pancreatitis. Dig Dis Sci 28:111–116, 1983
Whicher JT, Barnes MP, Brown A, Cooper MJ, Read R, Walters G, Williamson RCN: Complement activation and complement control proteins in acute pancratitis. Gut 23:944–950, 1982
Sumi H, Takasugi S, Toki N: Studies on Kallikrein-Kinin system in plasma of patients with acute pancreatitis. Clin Chim Acta 87:113–118, 1978
Ransom JH, Lackner H, Berman IR, Schinella R: The relationship of coagulation factors to clinical complications of pancreatitis. Surgery 81:502–511, 1977
Thompson AG: Proteinase inhibitors in experimental and clinical pancreatitis. Ann NY Acad Sci 146:540–547, 1968
MRC Multicentre Trial of Glucagon and Aprotinin: Death from acute pancreatitis. Lancet 2:632–635, 1977
Tanaka N, Tsuchiya R, Ishii K: Comparative clinical study of FOY and Trasylol in acute pancreatitis.In Kinins II: Systemic Proteases and Cellular Function. S Fujii, H Moriya, T Suzuki (eds). New York, Plenum, 1979, pp 367–378
Vercaigne D, Morcamp C, Martin JP, Joly JP, Hillmand B, Raoult JP: “Tryptic-like” activity in sera of patients with pancreatitis. Clin Chim Acta 106:269–277, 1980
Gullick HD: Differentiation of trypsin-like enzymes in human plasma. Clin Chem 18:1385–1394, 1972
Geokas MC, Largman C, Brodrick JW, Johnson JH: Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. Am J Physiol 236:E77-E83, 1979
Borgstrom A, Ohlsson K: Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. Scand J Clin Lab Invest 36:809–814, 1976
Masoero G, Andriulli A, Recchia S, Marchetto M, Benitti V, Verme G: Trypsin-like immunoreactivity in the diagnosis of acute pancreatitis. Scand J Gastroenterol 15 (Suppl 62): 21–25, 1980
Borgstrom A, Ohlsson K: Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis. Hoppe-Seyler's Z Physiol Chem 361:625–631, 1980
Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH: Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. Am J Physiol 237:E474-E480, 1979
Geokas MC, Largman C, Durie PR, Brodrick JW, Ray SB, O'Rourke M, Vollmer J: Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis. Am J Pathol 105:31–39, 1981
Aho HJ, Koskensalo M-L, Nevalainen TJ: Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol 15:411–416, 1980
Tsukamoto H, Reidelberger RD, Largman C: Long-term cannulation model for blood sampling and intragastric infusion in the rat. Am J Physiol 247:R595–599, 1984
Reidelberger RD, Tsukamoto H, Ray S, Largman C, Geokas MC: Trypsin immunoreactivity and trypsin-like amidase activity in plasma and ascites in experimental pancreatitis in rats. (submitted) Digestion
Largman C, Brodrick JW, Geokas MC: Radioimmunoassay determination of circulating pancreatic endopeptidases. Methods Enzymol 74:272–290, 1981
Brodrick JW, Largman C, Geokas MC, O'Rourke M, Ray SB: Clearance of circulating anionic and cationic pancreatic trypsinogen in the rat. Am J Physiol 239:511–515, 1980
Roll DE, Glew RH: Isolation and characterization of rat α1-antitrypsin. J Biol Chem 256:8190–8196, 1981
Gordon HA: The α-macroglobulins of rat serum. Biochem J 159:643–650, 1976
Rinderknecht H, Silverman P, Geokas MC, Haverback BJ: Determination of trypsin and chymotrypsin with Remazol brilliant blue-hide Clin Chim Acta 28:239–246, 1970
Ohlsson K, Ganrot P-O, Laurell C-B:In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog. Acta Chir Scand 137:113–121, 1971
Cohen AB: Mechanism of action of α1-antitrypsin. J Biol Chem 248:7055–7059, 1973
Harpel PC, Mosesson MW: Degradation of human fibrinogen by plasma α2-macroglobulin-enzyme complexes. J Clin Invest 52:2175–2184, 1973
Brodrick JW, Largman C, Ray SB, Geokas MC: proteolysis of parathyroid hormonein vitro by sera from acute pancreatitis patients. Proc Exp Biol Med 167:588–596, 1981
Largman C, Johnson JH, Brodrick JW, Geokas MC: Proinsulin conversion to desalanyl insulin by α2-macroglobulin bound trypsin. Nature 269:168–170, 1977
McMahon MJ, Bowen M, Mayer AD, Cooper EH: Relationship of α2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 147:164–170, 1984
Lasson A, Ohlsson K: Protease inhibitors in acute human pancreatitis: Correlation between biochemical changes and clinical course. Scand J Gastroenterol 19:779–786, 1984
Borgstrom A, Lasson A: Trypsin-α1-protease inhibitor complexes in serum and clinical course in acute pancreatitis. Scand J Gastroenterol 19:1119–1122, 1984
Durie PR, Gaskin KJ, Ogilvie JE, Smith CR, Forstner GG, Largman C: Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis. J Pediatr Gastroenterol Nutr 4:199–207, 1985
Ohlsson K: Elimination of125I-trypsin-α-macroglobulin complexes from blood by reticuloendothelial cells in dog. Acta Physiol Scand 81:269–272, 1971
Adham NF, Song MK, Haberfelde, GC: Relationship between the functional status of the reticuloendothelial system and the outcome of experimentally induced pancreatitis in young mice. Gastroenterology 84:461–469, 1983
Katayama K, Fujita T: Studies on biotransformation of elastate. IV. Tissue distribution of131I-labeled elastase and intracellular distribution in liver after intravenous administration in rats. Biochim Biophys Acta 336:178–190, 1974
Kramer SP, Plapinger RE, Bharadwaj PD, Patt, HH, Seligman, AM: Assay of trypsin activity of human serum with a chromogenic substrate, CBZ-diglycyl-l-arginine-2-naphthylamide hydrochloride (GGANA). J Surg Res 8:253–260, 1968
Author information
Authors and Affiliations
Additional information
This work was supported by the Research Service of the Veterans Administration and by an NIH grant (HL25408) to C.L.
Rights and permissions
About this article
Cite this article
Largman, C., Reidelberger, R.D. & Tsukamoto, H. Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats. Digest Dis Sci 31, 961–969 (1986). https://doi.org/10.1007/BF01303217
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01303217